Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost · Investor's Business Daily ALLISON GATLIN Mon, Apr 21, 2025, 2:09 PM 2 min read In This Article: DYN RNA SRPT BEAM NTLA Shares of gene therapy companies — including Sarepta Therapeutics — got a lift Monday after FDA's Marty Makary laid out his plans. Continue Reading View Comments Terms and Privacy Policy Your Privacy Choices Utah Privacy Notice More Info Recommended Stories